Edward Perry
Impact in
- Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
- Treatment of Major Depression
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 12
- Neuroscience and Neuropharmacology Research 8
- Pharmacology 16
- Treatment of Major Depression 9
- Cannabis and Cannabinoid Research 7
- Co-authors
- John H. Krystal (16 shared papers)Deepak Cyril D’Souza (14 shared papers)Ralitza Gueorguieva (10 shared papers)Thomas B. Cooper (5 shared papers)Gabriel Braley (7 shared papers)Ayşenil Belger (5 shared papers)Lisa Macdougall (3 shared papers)Yu‐Te Wu (1 shared paper)
- Journals
- Psychopharmacology (9 papers)Neuropsychopharmacology (5 papers)Schizophrenia Research (3 papers)The International Journal of Neuropsychopharmacology (2 papers)Frontiers in Psychiatry (1 paper)
- Partner nations
- United StatesSouth KoreaPuerto Rico
In The Last Decade
Edward Perry
45 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Biological Psychiatry 534
- Pharmacology 1.6k
- Cellular and Molecular Neuroscience 1.5k
- Cognitive Neuroscience 765
- Psychiatry and Mental health 599
Countries citing papers authored by Edward Perry
This map shows the geographic impact of Edward Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Perry more than expected).
Fields of papers citing papers by Edward Perry
This network shows the impact of papers produced by Edward Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Perry. The network helps show where Edward Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis Hit paper breakdown → | 2004 | 764 |
| 2 | 2003 | 423 | |
| 3 | 2005 | 258 | |
| 4 | 2004 | 212 | |
| 5 | 2008 | 208 | |
| 6 | 2006 | 167 | |
| 7 | 1998 | 128 | |
| 8 | 2009 | 111 | |
| 9 | 2002 | 108 | |
| 10 | 2008 | 99 | |
| 11 | 2008 | 94 | |
| 12 | 2007 | 92 | |
| 13 | 2008 | 89 | |
| 14 | 2012 | 64 | |
| 15 | 1983 | 57 | |
| 16 | 2014 | 44 | |
| 17 | 2006 | 43 | |
| 18 | 2006 | 40 | |
| 19 | 2004 | 40 | |
| 20 | 2006 | 39 |
About Edward Perry
Edward Perry is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Civil and Structural Engineering, Biological Psychiatry and Psychiatry and Mental health, having authored 47 papers that have together received 3.4k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (12 papers), Tryptophan and brain disorders (9 papers), Treatment of Major Depression (9 papers), Dam Engineering and Safety (8 papers), Neuroscience and Neuropharmacology Research (8 papers), Cannabis and Cannabinoid Research (7 papers), Schizophrenia research and treatment (6 papers) and Nicotinic Acetylcholine Receptors Study (6 papers). The work is most often cited by research in Biological Psychiatry (534 citations), Pharmacology (1.6k citations), Cellular and Molecular Neuroscience (1.5k citations), Cognitive Neuroscience (765 citations) and Psychiatry and Mental health (599 citations). Edward Perry has collaborated with scholars based in United States, South Korea and Puerto Rico. Frequent co-authors include John H. Krystal, Deepak Cyril D’Souza, Ralitza Gueorguieva, Thomas B. Cooper, Gabriel Braley, Ayşenil Belger, Lisa Macdougall, Yu‐Te Wu, Daniel H. Mathalon and Ralph E. Hoffman. Their work appears in journals such as Psychopharmacology, Neuropsychopharmacology, Schizophrenia Research, The International Journal of Neuropsychopharmacology and Frontiers in Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.